ready rx semaglutide reviews ODT Pills Willow GLP-1 Review 2026: Flat

The most consequential pending readout is TRANSCEND-T2D-2, the head-to-head trial pitting retatrutide against semaglutide in type 2 diabetes over 80 weeks

Compounded semaglutide is not FDA-approved as a finished product but is legally prepared by licensed 503A pharmacies under established guidelines

Compounded versions skip this process

Clinical trials have shown patients achieving higher weight loss percentages, faster improvements in metabolic health, and better long-term outcomes

What do clinicians, the FDA and investors view as success in this space

[12] FEHB Plans: Zepbound on 2026 Formulary Kaiser FEHB and PSHB plans confirm Zepbound on 2026 formularies at Tier 3/4 (specialty tier)